Department of Medicine, University of California San Diego, La Jolla, Calif.
Department of Physiology and Biophysics, University of Arkansas for Medical Sciences and Arkansas Children's Hospital Research Institute, Little Rock, Ark.
J Allergy Clin Immunol. 2018 Jan;141(1):329-338.e12. doi: 10.1016/j.jaci.2017.03.010. Epub 2017 Mar 30.
Group 2 innate lymphoid cells (ILC2s) expand in the lungs of mice during type 2 inflammation induced by the fungal allergen Alternaria alternata. The increase in ILC2 numbers in the lung has been largely attributed to local proliferation and whether ILC2s migrate from the circulation to the lung after Alternaria exposure is unknown.
We examined whether human (lung, lymph node, and blood) and mouse lung ILC2s express β and β integrin adhesion molecules and whether these integrins are required for trafficking of ILC2s into the lungs of mice.
Human and mouse ILC2s were assessed for surface expression of β and β integrin adhesion molecules by using flow cytometry. The role of β and β integrins in ILC2 trafficking to the lungs was assessed by in vivo blocking of these integrins before airway exposure to Alternaria in mice.
Both human and mouse lung ILC2s express high levels of β and β integrin adhesion receptors. Intranasal administration of Alternaria challenge reduced ILC2 numbers in the bone marrow and concurrently increased blood and lung ILC2 numbers. In vivo blocking of β integrins (CD18) significantly reduced ILC2 numbers in the lungs but did not alter ILC2 proliferation, apoptosis, and function. In contrast, in vivo blocking of β integrins or α integrins did not affect lung ILC2 numbers.
ILC2 numbers increase in the mouse lung not only through local proliferation but also through trafficking from the circulation into the lung using β rather than β or α integrins.
在真菌过敏原链格孢诱导的 2 型炎症中,2 型先天淋巴细胞 (ILC2) 在小鼠肺部扩增。肺部 ILC2 数量的增加在很大程度上归因于局部增殖,而 ILC2 在暴露于链格孢后是否从循环迁移到肺部尚不清楚。
我们研究了人类(肺、淋巴结和血液)和小鼠肺 ILC2 是否表达 β 和 β 整合素粘附分子,以及这些整合素是否是 ILC2 迁移到小鼠肺部所必需的。
通过流式细胞术评估人源和鼠源 ILC2 表面表达 β 和 β 整合素粘附分子的情况。通过在小鼠气道暴露于链格孢之前体内阻断这些整合素来评估β 和 β 整合素在 ILC2 向肺部转移中的作用。
人源和鼠源肺 ILC2 均表达高水平的β 和 β 整合素粘附受体。鼻内给予链格孢挑战会减少骨髓中的 ILC2 数量,同时增加血液和肺中的 ILC2 数量。体内阻断β 整合素 (CD18) 可显著减少肺部的 ILC2 数量,但不会改变 ILC2 的增殖、凋亡和功能。相比之下,体内阻断β 整合素或α 整合素不会影响肺部 ILC2 的数量。
ILC2 数量在小鼠肺部增加不仅通过局部增殖,而且通过使用β 而不是β 或α 整合素从循环中迁移到肺部来增加。